ANDY PICKETT ET AL: "Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool", TOXINS, vol. 3, no. 12, 12 January 2011 (2011-01-12), pages 63-81, XP055199954, DOI: 10.3390/toxins3010063 (B1)

CLIFFORD C. SHONE ET AL: "Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity", EUROPEAN JOURNAL OF BIOCHEMISTRY, vol. 151, no. 1, 1 August 1985 (1985-08-01), pages 75-82, XP055199874, ISSN: 0014-2956, DOI: 10.1111/j.1432-1033.1985.tb09070.x (B1)

EP-A1- 2 524 963 (B1)

KOZAKI S ET AL: "Activation of Clostridium botulinum type B and E derivative toxins with lysine-specific proteases", FEMS MICROBIOLOGY LETTERS, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 27, no. 2, 1 May 1985 (1985-05-01), pages 149-154, XP023919407, ISSN: 0378-1097, DOI: 10.1111/J.1574-6968.1985.TB00658.X [retrieved on 1985-05-01] (B1)

MALIZIO C ET AL: "Purification of Clostridium botulinum Type A Neurotoxin", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS, INC, US, vol. 145, 1 January 2000 (2000-01-01), pages 27-39, XP008123242, ISSN: 1064-3745, DOI: 10.1385/1-59259-052-7:27 [retrieved on 2008-02-05] (B1)

US-A- 5 846 929 (B1)

YU Y Z ET AL: "The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 27, no. 21, 11 May 2009 (2009-05-11), pages 2816-2822, XP026053630, ISSN: 0264-410X, DOI: 10.1016/J.VACCINE.2009.02.091 [retrieved on 2009-03-11] (B1)

US-A1- 2006 228 780 (B1)

US-A1- 2011 008 843 (B1)

US-A1- 2011 092 682 (B1)

WO-A1-2014/080206 (B1)

YAO ZHAO ET AL: "Peg Precipitation Coupled with Chromatography is a New and Sufficient Method for the Purification of Botulinum Neurotoxin Type B", PLOS ONE, vol. 7, no. 6, 28 June 2012 (2012-06-28), page e39670, XP055199984, DOI: 10.1371/journal.pone.0039670 (B1)

US-A1- 2005 238 669 (B1)